MedTrace Logo

Multimodal Intervention for Painful Diabetic Neuropathy: NeuOst Feasibility Trial

NCT06423391 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2025-02-27

No results posted yet for this study

Summary

This is the feasibility study of a single-site parallel three-armed participant-blinded controlled randomised efficacy trial of a 5-week course of the 'NeuOst treatment', compared to a designated control intervention, and to usual care only, for adults with pDPN.

Conditions

  • Painful Diabetic Neuropathy

Interventions

OTHER

NeuOst

As above

OTHER

Control Intervention

As above

OTHER

Usual Care

As above

Sponsors & Collaborators

  • Imperial College London

    collaborator OTHER

  • King's College London

    collaborator OTHER

  • University of Oxford

    collaborator OTHER

  • Universität Münster

    collaborator OTHER

  • University College of Osteopathy

    lead OTHER

Principal Investigators

  • David Hohenschurz-Schmidt, PhD · University College of Osteopathy / Imperial College London

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-04-30
Primary Completion
2025-05-01
Completion
2025-06-15

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06423391 on ClinicalTrials.gov